News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Farnum Rhonda
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Sold 1,807 shares
@ $9.47, valued at
$17.1k
|
|
| 08/22/2023 |
4
| Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 10,460 shares
@ $9.7, valued at
$101.5k
|
|
| 06/12/2023 |
4
| Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Sold 1,790 shares
@ $11.13, valued at
$19.9k
|
|
| 05/23/2023 |
4
| Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 5,567 shares
@ $11.21, valued at
$62.4k
|
|
| 03/13/2023 |
4
| Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Sold 4,000 shares
@ $10.2, valued at
$40.8k
|
|
| 03/03/2023 |
4
| Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 75,000 shares
@ $0 |
|
| 02/22/2023 |
4
| Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 7,119 shares
@ $10.44, valued at
$74.3k
|
|
| 11/22/2022 |
4
| Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 23,268 shares
@ $10.85, valued at
$252.5k
|
|
| 08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|